The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story
Abstract
PURPOSE: We review how the bacillus Calmette-Guerin vaccine evolved to become standard therapy for superficial bladder cancer. MATERIALS AND METHODS: We reviewed the historical literature describing the origin of the bacillus Calmette-Guerin vaccine as an anticancer agent and its singular success as the most effective immunotherapy used against a human neoplasm. RESULTS: The association between tuberculosis and cancer, and the demonstration that bacillus Calmette-Guerin invoked immunological reactivity, inhibiting tumor growth in experimental animal models, led to clinical trials showing that intravesical bacillus Calmette-Guerin eradicated and prevented recurrence of superficial bladder tumors. CONCLUSIONS: For the last 3 decades bacillus Calmette-Guerin therapy has remained the most effective local therapy for superficial bladder cancer, an outstanding example of successful translational medicine in urology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (1976) · Journal of Urology · doi:10.1016/s0022-5347(17)58737-6 · Cited by 1,791
Self-citationIntracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.101 · Cited by 1,533
Self-citationIntracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors
Morales, A. (1976) · The Journal of Urology · Cited by 978
Self-citationEffect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse
OLD, L. J., CLARKE, D. A., & BENACERRAF, B. (1959) · Nature · doi:10.1038/184291a0 · Cited by 539
Bacillus Calmette-guerin Immunotherapy of Superficial Bladder Cancer
Lamm, D. L., Thor, D. E., Harris, S. C., Reyna, J. A., Stogdill, V. D., & Radwin, H. M. (1980) · Journal of Urology · doi:10.1016/s0022-5347(17)55282-9 · Cited by 333
PEARL, R. (1929) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121646 · Cited by 200
La vaccination preventive contre la tuberculose par le "BCG"
Calmette, A. (1927) · Galiciana (Xunta de Galicia) · Cited by 119
La Vaccination Préventive Contre la Tuberculose par le “BCG”
Ravenel, M. P. (1928) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.18.8.1075-a · Cited by 27
Cited by
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Pettenati, C., & Ingersoll, M. A. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0055-4 · Cited by 457
A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Bellmunt, J., Powles, T., & Vogelzang, N. J. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.01.007 · Cited by 374
BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
Covián, C., Fernández-Fierro, A., Retamal-Díaz, A., Díaz, F. E., Vasquez, A. E., Lay, M. K., Riedel, C. A., González, P. A., Bueno, S. M., & Kalergis, A. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02806 · Cited by 328
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer
Biot, C., Rentsch, C. A., Gsponer, J. R., Birkhäuser, F. D., Jusforgues-Saklani, H., Lemaître, F., Auriau, C., Bachmann, A., Bousso, P., Demangel, C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003586 · Cited by 269
Metadata
- Authors
- Herr, H. W., & Morales, A.
- Venue
- Journal of Urology
- Published
- 2008-01
- Volume
- 179
- Issue
- 1
- Pages
- 53-56
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2132951532
- Cited by
- 353
- References
- 8
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story. https://app.cochat.ai/papers/10.1016/j.juro.2007.08.122
- The paper
- Herr, H. W., & Morales, A. (2008). History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story. Journal of Urology. https://doi.org/10.1016/j.juro.2007.08.122
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.